Literature DB >> 35154717

Depigmentation of the vulvar area: Is it an alarming sign?

Reem Diab1, Zahra Asadi Kani1, Ali Kaddah2,3, Mohammad Reza Pourani1, Fahimeh Abdollahimajd1,3, Hamideh Moravvej1.   

Abstract

A 34-year-old female patient presented with recurrent bilateral hypopigmented macules on the labia majora. The lesions were treated with topical steroids, which led to mild improvement, but erosive plaques developed after discontinuing the treatment. Histopathological findings were compatible with extramammary Paget disease (EMPD), which was treated with radical vulvectomy with no recurrence in the next months of follow-up.
© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Paget disease; extramammary Paget disease; hypopigmented macule; labia majora; vulvar lesion

Year:  2022        PMID: 35154717      PMCID: PMC8819715          DOI: 10.1002/ccr3.5356

Source DB:  PubMed          Journal:  Clin Case Rep        ISSN: 2050-0904


INTRODUCTION

Extramammary Paget's disease is a neoplasm occurring predominantly in women between 50–60 years, and it is often seen in the axillary, perianal, and anogenital areas. , Clinical presentation includes pruritic, erythematous plaques in the anogenital region (most frequently involving the labia majora) described as “strawberries and cream”. Occasionally, it may present with hypopigmented macules, which may lead to misdiagnosis with other diseases like vitiligo or lichen sclerosus. Herein, we report an early presentation for extramammary Paget's disease in a 34‐year‐old woman who presented early with recurrent bilateral hypopigmented macules. Early biopsy and diagnosis resulted in an excellent prognosis with no involvement of other organs.

CASE PRESENTATION

A 34‐year‐old female patient presented with mildly pruritic, hypopigmented macules bilaterally involving the labia majora. The problem had commenced two months beforehand, and the patient had used the fluocinolone acetonide and zinc oxide creams for about one month. Such therapy led to a mild improvement, but discontinuation was followed by the development of erosive erythematous plaques in the same area (Figure 1). The physical examination was unremarkable. A mucosal biopsy was obtained. Histopathological examination of the specimen revealed focal parakeratosis and mild epidermal acanthosis with diffuse infiltration of large neoplastic epithelial cells in singular form or in small clusters along the basal and supra‐basal layers of the epidermis. The tumor cells had large vesicular nuclei and pale eosinophilic cytoplasm with clear perinuclear halo. The underlying dermis revealed mild perivascular lymphocytic infiltrate. No intradermal neoplastic cell infiltrate was identified (Figure 2A). Immunohistochemistry (IHC) staining was carried out according to morphological findings, and the intra‐epidermal tumor cells were positive for the Pan Cytokeratin (CK‐PAN), cytokeratin (CK7), and carcinoembryonic antigen (CEA) (Figure 2B). The S100 proteins, Melan‐a and HMB45, were detected in the tumor cells. Clinical and histopathological findings were compatible with extramammary Paget disease (EMPD).
FIGURE 1

Hypopigmented macules bilaterally involving the labia majora

FIGURE 2

(A) Diffuse infiltration of large neoplastic epithelial along the basal and supra‐basal layers of the epidermis; H&E stain (×400). (B) Paget cells stained for CK7; immunohistological stain (×400)

Hypopigmented macules bilaterally involving the labia majora (A) Diffuse infiltration of large neoplastic epithelial along the basal and supra‐basal layers of the epidermis; H&E stain (×400). (B) Paget cells stained for CK7; immunohistological stain (×400)

DISCUSSION

Extramammary Paget disease is an intra‐epidermal neoplasm involving extramammary body areas like the perianal and anogenital regions, less often occurring in the axillary area. It predominantly arises from apocrine glands or keratinocytes as a primary malignant skin neoplasm. It occurs more frequently in women with a predilection for those aged between 50 and 80 years. Clinically, it presents as an erythematous plaque in the anogenital area with an average size of 5 cm. It most frequently involves the labia majora, followed by the labia minora, clitoris, perineum, and perineal area. Pruritus, soreness, and painful erosions are the most associated manifestations. Occasionally, hypopigmentation is evident, which may lead to misdiagnosis. The histological findings include Paget's cells distributed along the epidermis, usually with atypical nuclei and a pale cytoplasm.  Most often, Paget's cells are positive for epithelial membrane antigen (EMA), CEA, low molecular weight keratin, periodic acid–Schiff stain (PAS), Alcian blue, and mucicarmine. Differential diagnoses of EMPD are wide, including contact dermatitis, Bowen disease, lichen sclerosus, lichen simplex chronicus, pemphigus vegetans, and psoriasis. For this reason, detailed history, physical examination in addition to histopathological evaluation are essential for differentiating EMPD from other diseases. Nowadays, the treatment of choice for EMPD is surgical resection using Mohs microsurgery or the modified peripheral Mohs technique, which is the preferred treatment to reduce recurrence rates.  Treatment options for primary local lesions include wide local excision, or non‐surgical options if the patient is not a surgical candidate including topical imiquimod, photodynamic therapy, or radiotherapy. For regional lymph node metastases, the treatment of choice is lymph node dissection, while chemotherapy, anti‐HER2 antibody therapy, hormonal therapy, or immune checkpoint therapy are considered for treatment of distant metastases. In the described case, the patient had an uncommon presentation of EMPD that was confirmed histopathologically and via special IHC staining techniques. Nowadays immunohistochemical staining is used mainly in diagnosis of EMPD and distinguishing it from other diseases.  Paget cells are marked with low molecular weight cytokeratins (CK7 or CK20), periodic acid‐Schiff (PAS), GCDFP‐15, and CEA. After the diagnosis was established, a complete lymph nodes’ examination, colonoscopy, cystoscopy, and mammography were done and were all normal. All serum tumor markers, including CA 15–3, CEA, and CA 19–9, were also normal. Radical vulvectomy was done, and the tumor involved hair follicles with a size of 4.4 × 4.3 cm and showed stromal invasion 1 mm in depth. There was no lymphovascular invasion. As mentioned above, the most common presentation of this disease is well‐defined, scaly, erythematous plaques, most frequently described as “strawberries and cream,” leading to the typical symptom of pruritus. Our case at first had presented with non‐specific lesions (hypopigmented macules) with very mild or even unmentioned pruritus, misdiagnosed as vitiligo and lichen sclerosus et atrophicus. A topical corticosteroid was initiated, and there was a recurrence after it was discontinued. Hence, a biopsy was done, and the definite diagnosis was obtained. The classical erythematous lesions appeared shortly after confirmation of the diagnosis. Interestingly, the patient mentioned a family history of malignant melanoma for her aunt. According to a literature review, a history of association between EMPD and malignant melanoma has been reported in a few patients. However, so far, there is no precise explanation of the exact hereditary mechanisms concerning this association.  The family history of malignant melanoma and the early presentation of EMPD in our patient may highlight the possibility of a common genetic association between the two neoplasms that needs further studies for confirmation. According to this uncommon presentation of EMPD in our young patient, we recommend an early biopsy for every suspected recurrent vulvar hypopigmented lesion. An early biopsy can result in a better prognosis. Indeed, our patient had no other organ involvement because of the early diagnosis and definitive treatment.

CONFLICTS OF INTEREST

The authors have no conflicts of interest to declare.

AUTHOR CONTRIBUTIONS

HM was involved in the diagnosis and management of the patient and has been responsible for the clinical part of the manuscript. ZAK reported the result of histopathological evaluation. FA, RD, MRP, and AK did literature review and drafted the manuscript. HM, FA, RD, and AK were responsible for final editing of the manuscript, and coordinated the study. All authors have read and approved the final manuscript.

CONSENT

Written informed consent was obtained from the patient for publication of this case report and any accompanying images.
  5 in total

Review 1.  Mammary and extramammary Paget's disease.

Authors:  J Kanitakis
Journal:  J Eur Acad Dermatol Venereol       Date:  2007-05       Impact factor: 6.166

Review 2.  Extramammary Paget disease.

Authors:  Kayla St Claire; Alena Hoover; Kurt Ashack; Amor Khachemoune
Journal:  Dermatol Online J       Date:  2019-04-15

3.  Management of Extramammary Paget's Disease: A Case Report and Review of the Literature.

Authors:  Rosa Guerra; Subhasis Misra
Journal:  Case Rep Dermatol Med       Date:  2013-11-14

4.  Extramammary Paget's Disease and Melanoma: 2 Cases of Double Cancers.

Authors:  Erika Lydrup; Jais Oliver Berg; Sofie Vetli Hjorth; Lisbet Rosenkrantz Hølmich; Jørgen Lock-Andersen; Annette Hougaard Chakera
Journal:  Case Rep Dermatol       Date:  2020-05-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.